PEOPLE - Immunomedics (US) makes appointment:
This article was originally published in Clinica
Executive Summary
Robert DeLuccia has been appointed president and chief executive officer of Immunomedics, the US manufacturer of antibody-based cancer and infection imaging agents. He was previously with the drug company, Sanofi Winthrop Pharmaceuticals.